Last reviewed · How we verify
Tribendimidine — Competitive Intelligence Brief
marketed
Other
Small molecule
Live · refreshed every 30 min
Target snapshot
Tribendimidine (Tribendimidine) — First Affiliated Hospital of Guangxi Medical University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tribendimidine TARGET | Tribendimidine | First Affiliated Hospital of Guangxi Medical University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tribendimidine CI watch — RSS
- Tribendimidine CI watch — Atom
- Tribendimidine CI watch — JSON
- Tribendimidine alone — RSS
Cite this brief
Drug Landscape (2026). Tribendimidine — Competitive Intelligence Brief. https://druglandscape.com/ci/tribendimidine. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab